Abstract
Neurons and neuroglia that express steroidogenic enzymes are lost in NPC mice, and the synthesis of allopregnanolone (ALLO) is substantially diminished at birth and decreases further over time
. Treatment of NP-C mice with ALLO increases the lifespan, delays the onset of neurological impairment, induces a substantial increase of Purkinje and granular cell survival in the cerebellum and reduces cortical ganglioside accumulation [14] . ALLO treatment in NPC mice is also correlated with its ability to activate the pregnane-X-receptor (PXR)-dependent pathways, suggesting that ALLO may mediate some of its effects through PXR [15] . However, the mechanism by which neurosteroids provide neuroprotection is probably multifunctional.
Therefore, we wanted to address whether the loss of NPC1 function leads to oxidative stress and whether ALLO exerts an effect on the intracellular redox status.
Material and methods

Cells culture and treatments
Human fibroblasts were obtained from skin biopsies from five patients affected with the infantile form of NPC disease (3 males and 2 females, age at onset from 2 to 5 years) and three age-matched controls. All NPC patients presented with the classical biochemical phenotype characterized by massive lysosomal accumulation of cholesterol in cultured fibroblasts. The diagnosis was confirmed by sequencing both NPC1 and NPC2 genes. All patients had mutations in the NPC1 gene. This study was approved by the ethical committee of the IRCCS Burlo Garofolo, and written consent was obtained from all subjects. Fibroblasts from NPC patients (FNPC) and from normal controls (FNC) were cultured in RPMI 1640 medium supplemented with 10% (v/v) foetal calf serum (FCS), and 50 mg/ml penicillin/streptomycin (Gibco, Paisley, UK)
. Twenty-four hours before performing the experiments, the medium was replaced by serum-free medium supplemented with LDL (50 g/ml) unless otherwise specified. [16, 17] [19] . 
Human SH-SY5Y neuroblastoma cells were grown in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% (v/v) FCS, and 50 mg/ml penicillin/streptomycin (Gibco, Paisley, UK). NPC1-deficient cells were treated with ALLO (10 to 100 nM) (Steraloids, Newport, RI, USA), the synthetic enantiomer of ALLO, ent-ALLO (50 nM)
Assessment of oxidative stress markers
Filipin staining
Filipin staining was performed using the method described by BlanchetteMackie et al. [22] . Briefly 
Anthranilic acid (2-AA) labelling, NP-HPLC separation and quantification of glycolipid-derived oligosaccharides
The oligosaccharides released after treatment with ceramide glycanase were analysed using the method of Neville et al. [24] . 
Statistical analysis
Statistical analysis was performed using Student's t-test analysis. P Ͻ 0.05 was considered as statistically significant.
Results
Analysis of ROS
We first analysed the intracellular levels of ROS in fibroblasts from normal controls (FNC) and from NPC patients (FNPC) (Fig. 1A). ROS were significantly more abundant in FNPC than in FNC, cultured either in the presence (white bars) or absence (black bars) of serum. It is worth noting that this difference is more evident when cells were cultured in the absence of foetal calf serum, suggesting that FNPC may be more sensitive than FNC to serum starvation. We then treated FNPC with different concentrations of ALLO (10-100 nM) for 24 hrs, showing a dose-dependent reduction in intracellular ROS (Fig. 1B). A similar effect was observed when FNPC were treated for 1 hr with 10 mM of N-acetyl cysteine (NAC), a thiol-containing antioxidant precursor of reduced glutathione.
To determine whether the NPC deficiency caused the oxidative stress, we selectively knocked down the expression of NPC1 in primary cultures of fibroblasts and in human SHSY5Y neuroblastoma cells, using small interference RNA (siRNA). Forty-eight hours after transfection, the expression of the endogenous NPC1 protein was almost completely abolished in SHSY5Y cells, whereas it was reduced to 40% of the control in primary cultured fibroblasts ( Fig. 2A and B) Fig. 3 (A and B) [16] , reduces the intracellular levels of ROS to the same extent as treatment with natural ALLO (Fig. 3C and D) .
We determined whether ALLO reduces the intracellular levels of ROS by acting as a free radical scavenger. We assayed, in vitro, its ability to scavenge the stable free radical DPPH. As a control, we used the known free radical scavenger N-acetyl cysteine, NAC. As shown in Fig. 4 
GR, CAT and GSH/GSSG
To further characterize the intracellular redox state in FNPC, we evaluated the activity of GR and CAT, and the levels of total reduced (GSH) and oxidized (GSSG) glutathione in FNPC and FNC. Although no differences were found in the activity of GR and in the levels of total GSH and GSSG (data not shown), CAT activity was significantly reduced in FNPC with respect to FNC (Fig. 5A) . ALLO treatment (50 nM for 24 hrs) partially restored CAT activity to the levels found in FNC (Fig. 5A) . (Fig. 5B) .
Analysis of lipid peroxidation
Cellular response to oxidative stress
To determine whether impaired intracellular redox state would render FNPC cells more sensitive to apoptosis when exposed to an (Fig. 6) (Fig. 6, [25, 26] 
grey bars). A similar protective effect was observed when FNPC were treated for 1 hr with 10 N-acetyl cysteine, NAC (hatched bars).
NF-B is a target of ROS in FNPC
A major target of ROS is the transcription factor NF-B, which exists in the cytoplasm as a dimer bound to an inhibitory protein, IB. Oxidative stress triggers phosphorylation and degradation of IkB, causing the dissociation of the IB from the NF-B, which translocates to the nucleus and activates a variety of target genes
. To determine whether peroxide-induced apoptosis in FNPC is associated with increased activation of the NF-B signalling pathway, we measured the nuclear levels of NF-B and the cytosolic levels of IB in FNPC and FNC using Western blot analysis. No differences were found in the basal levels of NF-B in the nucleus and IB in the cytoplasm between FNPC and FNC (data
Fig. 2 NPC1 deficiency increases intracellular ROS. NPC1 protein expression was knocked down by siRNA in primary cultured fibroblasts and in SHSY5Y human neuroblastoma cells. (A) Western blot of endogenous NPC1 protein 48 hrs after transfection. (B) The intensity of NPC1 signals were normalized against actin and expressed as a percentage of the concentrations found in cells transfected with the control SiRNA (C) Filipin staining for cholesterol accumulation revealed massive accumulation of unesterified cholesterol in both cell types. (D) Intracellular levels of ROS in NPC1-knockdown cells. ROS was assessed by measuring fluorescence of dichlorodihydrofluorescein diacetate (DCF). Data are mean Ϯ S.D. of 3 independent experiments and are expressed as percentage of the value obtained in cells transfected with siControl (*P Ͻ 0.05). not shown). However, NF-kB in the nuclei of FNPC increased and IB in the cytoplasm decreased in response to H2O2 treatment, whereas FNC were not responsive (Fig. 7A: Western blots; B and C, quantitation of Western blots).
Under basal conditions, ALLO treatment significantly increased cytosolic IB in FNPC, whereas nuclear abundance of NF-B remained unchanged (Fig. 7D, Western blot; E and F, quantitation of blot). When FNPC were pretreated with ALLO before exposure
to H2O2, nuclear NFkB did not increase and cytosolic IkB did not decrease. Instead, ALLO completely prevented the H2O2-stimulated increases in nuclear NF-B and decreases in cytosolic IB, suggesting that ALLO might protect NPC cells from increased transcription of NF-B-dependent genes.
ALLO treatment did not reduce intracellular accumulation of GSLs and cholesterol
We determined whether the effect of ALLO Fig. 8 
) or cholesterol accumulation (data not shown). Thus, the rapid effects of ALLO on oxidative stress may be independent of long-term changes in GSL or cholesterol accumulation.
Discussion
Oxidative stress has been implicated in many neurodegenerative disorders [9] [10] [11] [28] . Fibroblasts from NPC patients may be exposed to chronic oxidative stress that renders them more sensitive to peroxideinduced apoptosis. These results are similar to those observed in fibroblasts from Gaucher disease patients [11] , suggesting a common pathogenic mechanism. The increased sensitivity to peroxide-induced apoptosis in fibroblasts from NPC patients might be mediated at least in part by activation of the NF-B pathway.
Neurosteroidogenic abnormalities have been found in NPC disease [14] . The mechanism by which neurosteroids provide neuroprotection is not understood, and it may involve both genomic and non-genomic actions. Non-genomic actions of neurosteroids mediated through neurotransmitter receptors have been studied extensively. Reduced progesterone derivatives such as ALLO can activate GABAA receptors [29, 30] , and some effects of ALLO on NPC mice appear to be mediated through GABAA receptors [14] . However, the synthetic enantiomer of ALLO, ent-ALLO, provided identical effects as natural ALLO in NPC1 mice [15] [16, 17] , it is possible that the effects of these compounds on ROS levels are mediated through direct steroid-membrane interactions.
The antioxidant effects of estrogens seem to be associated with their intrinsic free radical scavenger activity due to the presence of a phenolic-A ring (estrogens) [36] or a C3 hydroxyl group (estradiol) [37] . Although ALLO does not contain a phenolic A ring, a similar mechanism could be hypothesized. However, our data suggest that ALLO does not act as a free radical scavenger.
In the light of our results, it is possible to speculate that ALLO might reduce the intracellular concentrations of ROS by increasing CAT activity. The molecular mechanism by which ALLO restores CAT activity in FNPC needs to be further investigated. However, the rapid reduction of ROS levels suggests that ALLO would not mediate its effects on CAT activity through a transcriptional activation.
ALLO might protect NPC cells from peroxide-induced apoptosis through the inhibition of NF-B signalling. In NPC mice, ALLO suppresses the expression of TNF-␣ [13] , a cytokine that activates NF-B [38] . Taken together, these data suggest that the effects of ALLO on NF-B involve multiple pathways.
Recently, a reduction of ALLO concentrations was found in prefrontal cortex and in plasma of AD patients [39, 40] . Results obtain in the mouse model of AD suggest that ALLO may be a promising therapeutic strategy for treatment of AD [41, 42] . Because the role of oxidative stress in the pathophysiology of AD has been documented extensively [9, 43] , our results suggest that ALLO might act beneficially through similar mechanisms to reduce oxidative damage in both NPC and AD.
Successful treatment of NPC mice was reported with a single injection of ALLO at post-natal day 7 (P7) [14, 44] 
